CR9366A - "derivados de 1,2,4- triazinas, su preparacion y su aplicacion en terapeutica humana - Google Patents

"derivados de 1,2,4- triazinas, su preparacion y su aplicacion en terapeutica humana

Info

Publication number
CR9366A
CR9366A CR9366A CR9366A CR9366A CR 9366 A CR9366 A CR 9366A CR 9366 A CR9366 A CR 9366A CR 9366 A CR9366 A CR 9366A CR 9366 A CR9366 A CR 9366A
Authority
CR
Costa Rica
Prior art keywords
derivatives
triazins
preparation
application
alkyl
Prior art date
Application number
CR9366A
Other languages
English (en)
Inventor
Elisabeth Dupont-Passelaigue
Isabelle Leroy
Jean-Francois Patoiseau
Didier Junquero
Yves Rival
Andre Delton
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of CR9366A publication Critical patent/CR9366A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

La invencion se refiere a derivados de 3,5-dioxo-(2H, 4H)-1,2,4-triazina de la formula general I en los cuales -R1 y R2 pueden ser identicos o diferentes y representan un radical alquilo o alquenilo, lineal o ramificado C1-C7, un radical alquilo C1-C6 substituido con grupos tales como trifluormetilo, cicloalquilo C5-C6, nitrilo, alcoxicarbonilvinilo C1-C4, hidroxicarbonilvinilo, alcoxicarbonilo C1-C4, carboxilato, benciloxi o fenilo (para el cual el nucleo fenilo esta posiblemente sustituido con uno o mas grupos tales como alquilo C1-C4, alcoxi C1-C4, nitro, halogeno o trifluormetilo).
CR9366A 2005-03-03 2007-09-04 "derivados de 1,2,4- triazinas, su preparacion y su aplicacion en terapeutica humana CR9366A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502152A FR2882750B1 (fr) 2005-03-03 2005-03-03 Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine

Publications (1)

Publication Number Publication Date
CR9366A true CR9366A (es) 2008-02-12

Family

ID=35116027

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9366A CR9366A (es) 2005-03-03 2007-09-04 "derivados de 1,2,4- triazinas, su preparacion y su aplicacion en terapeutica humana

Country Status (27)

Country Link
US (1) US7713971B2 (es)
EP (1) EP1856065B1 (es)
JP (1) JP5269420B2 (es)
KR (1) KR20070112230A (es)
CN (1) CN101155790A (es)
AR (1) AR053155A1 (es)
AT (1) ATE448211T1 (es)
AU (1) AU2006219802A1 (es)
BR (1) BRPI0607567A2 (es)
CA (1) CA2599848A1 (es)
CR (1) CR9366A (es)
DE (1) DE602006010337D1 (es)
ES (1) ES2336823T3 (es)
FR (1) FR2882750B1 (es)
IL (1) IL185586A0 (es)
MA (1) MA29343B1 (es)
MX (1) MX2007010787A (es)
MY (1) MY140662A (es)
NI (1) NI200700224A (es)
NO (1) NO20074881L (es)
PL (1) PL1856065T3 (es)
PT (1) PT1856065E (es)
RU (1) RU2007136027A (es)
TN (1) TNSN07335A1 (es)
TW (1) TW200643016A (es)
WO (1) WO2006092507A1 (es)
ZA (1) ZA200707730B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736229C (en) * 2008-09-05 2015-06-09 Acucela Inc. Sulfur-linked compounds for treating opthalmic diseases and disorders
EP2612669A4 (en) 2010-08-31 2014-05-14 Snu R&Db Foundation USING THE FÖTAL REPROGRAMMING OF A PPAR AGONIST
CN107074823B (zh) * 2014-09-05 2021-05-04 基因泰克公司 治疗性化合物及其用途
TWI884745B (zh) * 2018-10-12 2025-05-21 美商拓臻股份有限公司 甲狀腺素受體β促效劑化合物
CN111320609A (zh) 2018-12-13 2020-06-23 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
AU2020336272A1 (en) 2019-08-23 2022-04-14 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
WO2021050945A1 (en) 2019-09-12 2021-03-18 Terns, Inc. Thyroid hormone receptor beta agonist compounds
EP4568664B1 (en) 2023-04-07 2026-04-01 Terns Pharmaceuticals, Inc. Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
UA82048C2 (uk) * 2000-11-10 2008-03-11 Эли Лилли Энд Компани Агоністи альфа-рецепторів, активованих проліфератором пероксисом
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds
FR2866339B1 (fr) * 2004-02-18 2006-05-05 Pf Medicament Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine

Also Published As

Publication number Publication date
ATE448211T1 (de) 2009-11-15
ZA200707730B (en) 2008-05-28
CA2599848A1 (fr) 2006-09-08
JP2008531662A (ja) 2008-08-14
PL1856065T3 (pl) 2010-04-30
NI200700224A (es) 2008-03-27
US7713971B2 (en) 2010-05-11
EP1856065B1 (fr) 2009-11-11
IL185586A0 (en) 2008-01-06
AR053155A1 (es) 2007-04-25
KR20070112230A (ko) 2007-11-22
WO2006092507A1 (fr) 2006-09-08
TNSN07335A1 (fr) 2008-12-31
ES2336823T3 (es) 2010-04-16
PT1856065E (pt) 2010-02-10
BRPI0607567A2 (pt) 2011-10-18
TW200643016A (en) 2006-12-16
FR2882750B1 (fr) 2007-05-11
CN101155790A (zh) 2008-04-02
MY140662A (en) 2010-01-15
NO20074881L (no) 2007-11-27
WO2006092507A8 (fr) 2007-11-01
US20080167313A1 (en) 2008-07-10
MA29343B1 (fr) 2008-03-03
MX2007010787A (es) 2007-09-25
AU2006219802A1 (en) 2006-09-08
FR2882750A1 (fr) 2006-09-08
RU2007136027A (ru) 2009-04-10
JP5269420B2 (ja) 2013-08-21
DE602006010337D1 (de) 2009-12-24
EP1856065A1 (fr) 2007-11-21

Similar Documents

Publication Publication Date Title
CR9366A (es) "derivados de 1,2,4- triazinas, su preparacion y su aplicacion en terapeutica humana
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
CR8986A (es) Isoxazoles sustituidos como fungicidas
CY1119049T1 (el) Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια
GT200500179BA (es) Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
CO6270363A2 (es) Novedosos compuestos erivados aromaticos como inhibidores de c-fms kinase
AR055635A1 (es) Uso de sulfonanilidas como herbicidas
UY30748A1 (es) Compuesto0s novedosos
SV2010003502A (es) Fungicidas novedosos
UY30115A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion en terapeutica
DK1761520T3 (da) Kinaseinhibitorer
SV2010003514A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas
SV2011003825A (es) Nuevos derivados de acilaminobenzamida
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
UY29388A1 (es) Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica.
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
ZA200702534B (en) Personal care compositions with saits of hydroxypropyl triaiklammonium substituted mono-saccharide
GT200600117A (es) Nuevos compuestos farmaceuticos
AR062082A1 (es) Derivados de piridazina con actividad microbicida
UY29690A1 (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparación y su aplicación en terapéutica.
UY28434A1 (es) Compuestos
AR072103A1 (es) Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)